Clinical Report: Dry Eye Dx and Tx: Tailoring the Tear Reservoir

Overview

This report discusses the increasing use of scleral lenses for managing dry eye and ocular surface disease, highlighting the importance of tailored filling solutions. Recent studies indicate that specific formulations can significantly improve patient symptoms and ocular surface health.

Background

Dry eye disease (DED) is a prevalent condition that can severely impact patients' quality of life. Scleral lenses have emerged as a viable treatment option for patients with moderate to severe DED, particularly when conventional therapies fail. The choice of filling solution for these lenses is critical, as it can influence symptom relief and ocular surface integrity.

Data Highlights

No numerical data provided in the source material.

Key Findings

Clinical Implications

Eyecare practitioners should consider the type of filling solution used in scleral lenses, as it can greatly affect patient comfort and symptom management. Tailoring the filling solution to individual patient needs may enhance treatment outcomes for those with dry eye disease.

Conclusion

The findings underscore the importance of personalized treatment approaches in managing dry eye disease with scleral lenses. Continued research and clinical practice adjustments are necessary to optimize patient care.

References

1. Schornack MM, Fogt J, Nau A, Nau CB, Harthan JS, Cao D, Shorter E. Cont Lens Anterior Eye, 2023 -- Scleral lens prescription and management practices: emerging consensus.
2. Schornack MM, Nau CB, Harthan J, Shorter E, Nau A, Fogt J. Eye Contact Lens, 2023 -- Current trends in scleral lens prescription, management, and evaluation.
3. Tan J, Peguda R, Siddireddy JS, Briggs N, Stapleton F. Eye Contact Lens, 2022 -- Subjective responses to various filling solutions in the posterior fluid reservoir of miniscleral lenses at application.
4. Vilares Morgado R, Moura R, Moreira R, Falcão-Reis F, Pinheiro-Costa J. Cureus, 2023 -- New promising therapeutic approach for refractory corneal epithelial defects.
5. Nakhla MN, Patel R, Crowley E, Li Y, Peiris TB, Brocks D. Clin Ophthalmol, 2024 -- Utilizing PROSE as a drug delivery device for preservative-free cyclosporine 0.05% for the treatment of dry eye disease: a pilot study.
6. contact lens spectrum — Dry Eye Dx and Tx
7. contact lens spectrum — Dry Eye Dx and Tx: Tech’s Role in Modern Dry Eye Diagnostics
8. contact lens spectrum — Dry Eye Dx and Tx: Malfunctioning Mucins
9. Contact Lens Spectrum — Dry Eye Dx and Tx
10. Dry Eye Dx and Tx
11. Dry Eye Dx and Tx: Tech’s Role in Modern Dry Eye Diagnostics
12. Dry Eye Dx and Tx: Malfunctioning Mucins
13. Dry Eye Syndrome Preferred Practice Pattern®
14. Prospective pilot randomized controlled study of mini-scleral lenses versus rigid gas permeable lenses in irregular cornea with dry eye
15. Effects of scleral-lens oxygen transmissibility on corneal thickness: A pilot study - ScienceDirect